SUTCLIFFE, J. Gregor,BLOOM, Floyd E.,HILBUSH, Brian S.
申请号：
HUE09761084
公开号：
HUE027027T2
申请日:
2009.11.13
申请国别(地区):
HU
年份:
2016
代理人:
摘要：
The present invention relates to methods and compositions for modulating levels of amyloid-&bgr； peptide (A&bgr；) exhibited by non-neuronal (i.e., peripheral) cells, fluids, or tissues. The invention also relates to modulation of A&bgr； levels via selective modulation (e.g., inhibition) of &gamma；-secretase activity. The invention also relates to methods of preventing, treating or ameliorating the symptoms of a disorder, including but not limited to an A&bgr；-related disorder, by administering a compound that result in the modulation of &gamma；-secretase in a non-neuronal tissue, either directly or indirectly to prevent, treat or ameliorate the symptoms of a brain A&bgr； disorder, such as Alzheimer's disease.
